Cibc Asset Management Inc Summit Therapeutics Inc. Transaction History
Cibc Asset Management Inc
- $28 Billion
- Q4 2024
A detailed history of Cibc Asset Management Inc transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Cibc Asset Management Inc holds 21,577 shares of SMMT stock, worth $458,942. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,577
Previous 20,445
5.54%
Holding current value
$458,942
Previous $447,000
13.87%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SMMT
# of Institutions
232Shares Held
82.9MCall Options Held
1.67MPut Options Held
2.64M-
Baker Bros. Advisors LP New York, NY24.4MShares$520 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$248 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$168 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$139 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$119 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.28B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...